Atlas Trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Clinical trial NCT01164904 · TERMINATED

Trial details

NCT number
NCT01164904
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2010-07-01
Primary completion
2013-01-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.